Conferences

ecancer travels so that you don't have to. Expore the latest conference coverage in global oncology and find out where we are going next.
Bookmark and Share

NCRI 2012

4 - 7 Nov 2012
ACV - AUSTRIA CENTER VIENNA, Vienna, Austria
Patient led funding for clinical trials
Dr Ian Lewis – Tenovus, Cardiff, UK
Patient led funding for clinical trials ( Dr Ian Lewis – Tenovus, Cardiff, UK  )
15 Nov 2012
Advances in haemato-oncological treatment options
Prof Kenneth Anderson – Dana Farber Cancer Institute, Boston, UK
Advances in haemato-oncological treatment options ( Prof Kenneth Anderson – Dana Farber Cancer Institute, Boston, UK )
15 Nov 2012
Benefits of partaking in clinical trials
Lt. Col. David Hamilton - Lord Kitchener National Memorial Fund and NHS National...
Benefits of partaking in clinical trials ( Lt. Col. David Hamilton - Lord Kitchener National Memorial Fund and NHS National Cancer Peer Review, UK  )
15 Nov 2012
Perception of inequalities in care and cancer registries
Sir Michael Richards – Department of Health, UK
Perception of inequalities in care and cancer registries ( Sir Michael Richards – Department of Health, UK )
15 Nov 2012
Collaborations in clinical trials to bring new drugs to patients earlier
Dr Matt Seymour – National Cancer Research Network
Collaborations in clinical trials to bring new drugs to patients earlier (  Dr Matt Seymour – National Cancer Research Network  )
14 Nov 2012
Therapeutic exercise for patients with advanced cancer
Dr Matthew Maddocks – University of Nottingham, UK
Therapeutic exercise for patients with advanced cancer ( Dr Matthew Maddocks – University of Nottingham, UK  )
14 Nov 2012
Inequalities in cancer incidence, mortality and survival
Dr Michel Coleman - London School of Hygiene and Topical Medicine, London, UK
Inequalities in cancer incidence, mortality and survival ( Dr Michel Coleman - London School of Hygiene and Topical Medicine, London, UK )
14 Nov 2012
Cancer in developing countries
Dr Ian Magrath – International Network for Cancer Research and Treatment, Brusse...
Cancer in developing countries ( Dr Ian Magrath – International Network for Cancer Research and Treatment, Brussels, Belgium )
14 Nov 2012
Benefit of exercise to cancer survivors
Dr Johannes Brug – VU University Medical Centre, Amsterdam, Netherlands
Benefit of exercise to cancer survivors ( Dr Johannes Brug – VU University Medical Centre, Amsterdam, Netherlands )
14 Nov 2012
Management of hepatocellular carcinoma
Dr Jean-Francois Dufour – University of Bern, Switzerland
Management of hepatocellular carcinoma ( Dr Jean-Francois Dufour – University of Bern, Switzerland )
14 Nov 2012
Development of future cancer treatments
Dr Herbie Newell - Northern Institute for Cancer Research, Newcastle, UK
Development of future cancer treatments ( Dr Herbie Newell - Northern Institute for Cancer Research, Newcastle, UK )
14 Nov 2012
Tissue donation and clinical trials
Adrienne Morgan – VNCRI & NCRN Consumer Liaison Group
Tissue donation and clinical trials  ( Adrienne Morgan – VNCRI & NCRN Consumer Liaison Group )
14 Nov 2012
The importance of hereditary genes to cancer susceptibility
Dr Judy Garber – Dana Farber Cancer Institute, Boston, USA
The importance of hereditary genes to cancer susceptibility ( Dr Judy Garber – Dana Farber Cancer Institute, Boston, USA )
14 Nov 2012
Drug susceptibility in cancer cell lines
Dr Lodewyk Wessels – Netherlands Cancer Institute, Amsterdam
Drug susceptibility in cancer cell lines ( Dr Lodewyk Wessels – Netherlands Cancer Institute, Amsterdam )
14 Nov 2012
Depression in cancer patients
Prof Mari Lloyd-Williams – University of Liverpool, UK
Depression in cancer patients ( Prof Mari Lloyd-Williams – University of Liverpool, UK )
14 Nov 2012
Influence of cachexia on chemotherapy toxicity
Dr Michael Sawyer – University of Alberta, Canada
Influence of cachexia on chemotherapy toxicity ( Dr Michael Sawyer – University of Alberta, Canada )
14 Nov 2012
Advances in the treatment of colorectal cancer
Dr Patrick Johnston - Queens University, Belfast, UK
Advances in the treatment of colorectal cancer ( Dr Patrick Johnston - Queens University, Belfast, UK )
14 Nov 2012
New genetic sub-types of breast, ovarian and prostate cancer
Dr Paul Pharoah – University of Cambridge, UK
New genetic sub-types of breast, ovarian and prostate cancer ( Dr Paul Pharoah – University of Cambridge, UK )
14 Nov 2012
A new approach to charity helpline services
Dr Rachel Iredale – Tenovus, Cardiff, UK
A new approach to charity helpline services ( Dr Rachel Iredale – Tenovus, Cardiff, UK )
14 Nov 2012
A national study of cancer patient experiences
Dr Reg Race – Quality Health, Debyshire, UK
A national study of cancer patient experiences  ( Dr Reg Race – Quality Health, Debyshire, UK )
14 Nov 2012
Inequalities in cancer treatments
Dr Tony Moran – Christie NHS Foundation, Manchester, UK
Inequalities in cancer treatments ( Dr Tony Moran – Christie NHS Foundation, Manchester, UK )
14 Nov 2012
Advances in the treatment of prostate cancer
Prof Malcolm Mason – Cardiff University, UK
Advances in the treatment of prostate cancer ( Prof Malcolm Mason – Cardiff University, UK )
14 Nov 2012
Diet and exercise interventions for cancer survivors
Prof Wendy Demark-Wahnefried – UAB Comprehensive Cancer Center, Birmingham, Alab...
Diet and exercise interventions for cancer survivors ( Prof Wendy Demark-Wahnefried – UAB Comprehensive Cancer Center, Birmingham, Alabama, USA )
14 Nov 2012
Participation in clinical trials
Richard Stephens – VNCRI and NCRN Consumer Liaison Groups
Participation in clinical trials ( Richard Stephens – VNCRI and NCRN Consumer Liaison Groups )
14 Nov 2012
Patient involvement in improvements in standard of care
Tom Haswell - VNCRI and NCRN Consumer Liaison Groups
Patient involvement in improvements in standard of care ( Tom Haswell - VNCRI and NCRN Consumer Liaison Groups )
14 Nov 2012
Benefits of participating in clinical trials and patient liaison groups
Shirley Harrison - VNCRI and NCRN Consumer Liaison Groups
Benefits of participating in clinical trials and patient liaison groups ( Shirley Harrison - VNCRI and NCRN Consumer Liaison Groups )
14 Nov 2012